BTCY - Biotricity Inc. Stock Price, Fair Value and News

$0.48-0.02 (-4.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BTCY Price Action

Last 7 days

-4%

Last 30 days

-11.1%

Last 90 days

-20%

Trailing 12 Months

65.5%

BTCY RSI Chart

BTCY Valuation

Market Cap

13.3M

Price/Earnings (Trailing)

-2.89

Price/Sales (Trailing)

0.88

EV/EBITDA

-18.2

Price/Free Cashflow

-29.87

BTCY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BTCY Fundamentals

BTCY Revenue

Revenue (TTM)

15.1M

Rev. Growth (Yr)

18.95%

Rev. Growth (Qtr)

0.3%

BTCY Earnings

Earnings (TTM)

-4.6M

Earnings Growth (Yr)

50.55%

Earnings Growth (Qtr)

-14.93%

BTCY Profitability

Operating Margin

79.84%

EBT Margin

-30.02%

Return on Equity

13.79%

Return on Assets

-72.9%

Free Cashflow Yield

-3.35%

BTCY Investor Care

Shares Dilution (1Y)

13.95%

Diluted EPS (TTM)

-0.11

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	13.8M	14.5M	15.1M	0
2024	12.1M	12.2M	12.6M	13.3M
2023	9.6M	10.6M	11.1M	11.6M
2022	7.7M	7.9M	8.5M	9.0M
2021	3.4M	4.7M	5.8M	6.7M
2020	1.4M	1.5M	1.9M	2.6M
2019	414.6K	724.0K	952.2K	1.2M
2018	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Biotricity Inc.

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

CEO	Dr. Waqaas Al-Siddiq Ph.D.
WEBSITE	biotricity.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	55

Biotricity Inc. Frequently Asked Questions

What is the ticker symbol for Biotricity Inc.? What does BTCY stand for in stocks?

BTCY is the stock ticker symbol of Biotricity Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Biotricity Inc. (BTCY)?

As of Wed Dec 03 2025, market cap of Biotricity Inc. is 13.34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BTCY stock?

You can check BTCY's fair value in chart for subscribers.

Is Biotricity Inc. a good stock to buy?

The fair value guage provides a quick view whether BTCY is over valued or under valued. Whether Biotricity Inc. is cheap or expensive depends on the assumptions which impact Biotricity Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BTCY.

What is Biotricity Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, BTCY's PE ratio (Price to Earnings) is -2.89 and Price to Sales (PS) ratio is 0.88. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BTCY PE ratio will change depending on the future growth rate expectations of investors.